Treatment benefits for tPA are highest if administered within 3 hours of stroke onset [16,18,19] but can extend beyond the 3-hour window [20], with tPA considered safe for eligible patients up to 4.5 hours after stroke onset [21]. The gene discussed is PLAT; the disease is Stroke.